fbpx
Wikipedia

Allison McGeer

December 15, 2023

Allison Joan McGeer FRCPC (born 1953) is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Allison McGeer
Born1953 (age 69–70)
Alma materUniversity of Toronto (BS, MSc, MD)
Known forPandemic response, SARS coronavirus research, vaccine approval, public health guidance
Scientific career
InstitutionsSinai Health System
Dalla Lana School of Public Health
Lunenfeld-Tanenbaum Research Institute
Department of Laboratory Medicine & Pathobiology at the University of Toronto

Early life and education edit

In 1974, McGeer earned a B.Sc. in biochemistry from the University of Toronto.[1] She earned a master's degree and then an M.D. in 1982.[1][2] She trained in internal medicine and infectious diseases at the University of Toronto. From 1989 to 1990, McGeer was a clinical fellow in hospital epidemiology at Yale New Haven Hospital.[2]

Career edit

In 1989, McGeer joined the Sinai Health System, where she specialised in microbiology.[2] She holds a joint position as Professor in the Department of Laboratory Medicine and Pathobiology and of Infectious Diseases at the Dalla Lana School of Public Health.[3]

At the University of Toronto, she has focussed on developing mechanisms to stop the spread of infectious diseases in hospitals and care homes.[2][4] McGeer has studied the impact of influenza on hospital staff. She encouraged people of all ages to receive the universal flu vaccine and supported hospitals in improving their influenza testing.[5] She also contributed to a review of influenza diagnosis among older hospitalized patients on behalf of the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network.[6]

She is the director of infection control, and works as a microbiologist and infectious disease consultant at the Mount Sinai Hospital. Her staff directory page acknowledges funding through an unrestricted educational grant from Pfizer Canada.[2]

McGeer studies the prevention and management of bacterial and viral infections.[7] Her primary areas of research interest are the prevention of healthcare associated infection, the epidemiology of influenza, and adult immunization. She has received research grants from Pfizer and Seqirus, as well as personal and consulting fees from AstraZeneca, GlaxoSmithKline, Janssen, Medicago, Merck, Moderna, and Sanofi Pasteur.[8][9][10]

SARS and MERS edit

McGeer led the investigations into Severe Acute Respiratory Syndrome (SARS) in Toronto.[11][12][13][14] She was based at the Ontario SARS emergency operation centre. At the time, she contracted the disease,[15] and accidentally exposed several other health officials to the disease.[16] The health officials were quarantined and did not develop the disease. The basic reproduction number of severe acute respiratory syndrome-related coronavirus (SARS-CoV) was between 2.2 and 3.7, but super-spreading events (highly efficient transmission of the virus) occurred in some hospital settings.[17][18] McGeer believes that Toronto eliminated SARS by isolating people who were infected or at risk from the virus, preventing its spread.[19] A study the critical care units of Toronto's hospitals found that the consistent use of N95 masks was an effective way to protect nurses.[17][20] During the 2013 MERS outbreak, McGeer visited Saudi Arabia with the World Health Organization to help to track the spread of the virus.[21][22][23] Through careful monitoring of the air, food and water supply, McGeer helped to control the spread of the virus.[21]

COVID-19 pandemic edit

Throughout the COVID-19 pandemic McGeer provided health advice to the Canadian public,[24][25][26] including as a member of the Ontario COVID-19 Science Advisory Table.[27] She also serves on Canada's COVID-19 Expert Panel, assembled by Chief Science Advisor of Canada Dr. Mona Nemer to assist in providing advice and guidance to Prime Minister Justin Trudeau and the federal government.[28] In late January 2020, McGeer expressed concerns over the ability to contain SARS-CoV-2,[29][30] particularly the unknown incubation period, which makes it difficult to track and quarantine people who have been exposed.[31] In early March she emphasized the need for Canadians to follow public health advice to prevent the widespread transmission of SARS-CoV-2.[32] According to McGeer, the most important guidance was to limit social contact and stay at home when feeling unwell.[25][32][33]

McGeer started to investigate how long SARS-CoV-2 can survive in air in March 2020.[34] She was interested in how exhaled droplets, which contain both water and the virus, may become an infective aerosol that is light enough to be transported by air currents.[34] Caroline Duchaine, an aerosol specialist at the Université Laval, thinks that the virus may not be as potent in aerosol form, losing parts of its spiky protein shell as it dries out in the air.[34] McGeer and Duchaine are interested in how the virus survives in air in a hospital setting, particularly around patients who are being intubated.[34] She hopes her research will provide insight as to whether face masks should be worn to reduce the transmission of the virus.[34] At the time, the Centers for Disease Control and Prevention were considering whether to advise members of the public to wear masks when they left the house, and they had been made mandatory in the Czech Republic.[35]

In her role at Mount Sinai Hospital, McGeer acted as a local principal investigator for the "CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness" (CONCOR-1) study.[36] She also served as a principal investigator on a study examining the association between frailty and outcomes of COVID-19 infection.[37]

In May 2021, McGeer explained that National Advisory Committee on Immunization (NACI) deliberations to approve COVID-19 vaccines couldn't be made available to the public because the agency "has nothing like the budget or staff that would be needed" to do so. While NACI is mandated to "gather and evaluate the available data relevant to vaccines," McGeer also noted "they are not adequately resourced for rapid and comprehensive scientific assessment."[38] She welcomed NACI's September 2021 recommendation of a COVID-19 vaccine booster shot for residents of long-term and congregate care facilities, citing evidence of waning immunity among this population.[39]

McGeer was recruited as a member of the newly formed Ontario Immunization Advisory Committee (OIAC), created by Chief Medical Officer of Health Kieran Moore in August 2021 to work on provincial vaccine programs (including for COVID-19).[40]

Membership edit

Awards edit

Selected works and publications edit

 
Scholia has an author profile for Allison McGeer.
  • Chen, Danny K.; McGeer, Allison; de Azavedo, Joyce C.; Low, Donald E. (1999-07-22). "Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada". New England Journal of Medicine. 341 (4): 233–239. doi:10.1056/NEJM199907223410403. ISSN 0028-4793. PMID 10413735.   Wikidata ()
  • Nuorti, J. Pekka; Butler, Jay C.; Farley, Monica M.; Harrison, Lee H.; McGeer, Allison; Kolczak, Margarette S.; Breiman, Robert F. (2000-03-09). "Cigarette Smoking and Invasive Pneumococcal Disease". New England Journal of Medicine. 342 (10): 681–689. doi:10.1056/NEJM200003093421002. ISSN 0028-4793. PMID 10706897.  Wikidata ()
  • Poutanen, Susan M.; Low, Donald E.; Henry, Bonnie; Finkelstein, Sandy; Rose, David; Green, Karen; Tellier, Raymond; Draker, Ryan; Adachi, Dena; Ayers, Melissa; Chan, Adrienne K. (2003-05-15). "Identification of Severe Acute Respiratory Syndrome in Canada". New England Journal of Medicine. 348 (20): 1995–2005. doi:10.1056/NEJMoa030634. ISSN 0028-4793. PMID 12671061.   Wikidata ()
  • Assiri, Abdullah; McGeer, Allison; Perl, Trish M.; Price, Connie S.; Al Rabeeah, Abdullah A.; Cummings, Derek A.T.; Alabdullatif, Zaki N.; Assad, Maher; Almulhim, Abdulmohsen; Makhdoom, Hatem; Madani, Hossam; Alhakeem, Rafat; Al-Tawfiq, Jaffar A.; Cotten, Matthew; Watson, Simon J.; Kellam, Paul; Zumla, Alimuddin I.; Memish, Ziad A. (August 2013). "Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus". New England Journal of Medicine. 369 (5): 407–416. doi:10.1056/NEJMOA1306742. PMC 4029105. PMID 23782161.   Wikidata ()
  • Alhazzani, Waleed; Møller, Morten Hylander; Arabi, Yaseen M.; Loeb, Mark; Gong, Michelle Ng; Fan, Eddy; Oczkowski, Simon; Levy, Mitchell M.; Derde, Lennie; Dzierba, Amy; Du, Bin; Aboodi, Michael; Wunsch, Hannah; Cecconi, Maurizio; Koh, Younsuck; Chertow, Daniel S.; Maitland, Kathryn; Alshamsi, Fayez; Belley-Cote, Emilie; Greco, Massimiliano; Laundy, Matthew; Morgan, Jill S.; Kesecioglu, Jozef; McGeer, Allison; Mermel, Leonard; Mammen, Manoj J.; Alexander, Paul E.; Arrington, Amy; Centofanti, John E.; et al. (2020). "Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)". Intensive Care Medicine. 46 (5): 854–887. doi:10.1007/s00134-020-06022-5. PMC 7101866. PMID 32222812.

See also edit

References edit

  1. ^ a b . University of Toronto Medicine Magazine. Faculty of Medicine. 26 March 2014. Archived from the original on 28 June 2014. Retrieved 8 April 2020.
  2. ^ a b c d e f g "Staff Directory: Allison McGeer". eportal.mountsinai.ca. Retrieved 2020-04-06.
  3. ^ . ihpme.utoronto.ca. Archived from the original on 2016-08-21. Retrieved 2020-04-06.
  4. ^ . www.lmp.utoronto.ca. Archived from the original on 2020-04-06. Retrieved 2020-04-06.
  5. ^ "Dr. Allison McGeer answers common questions about the flu and the flu shot". Sinai Health. 2018-10-17. Retrieved 2020-04-06.
  6. ^ Andrew, Melissa K.; McElhaney, Janet E.; McGeer, Allison A.; Hatchette, Todd F.; Leblanc, Jason; Webster, Duncan; Bowie, William; Poirier, Andre; Nichols, Michaela K.; McNeil, Shelly A.; Investigators, on behalf of the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance Network (2020-03-09). "Influenza surveillance case definitions miss a substantial proportion of older adults hospitalized with laboratory-confirmed influenza: A report from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network". Infection Control & Hospital Epidemiology. 41 (5): 499–504. doi:10.1017/ice.2020.22. ISSN 0899-823X. PMID 32146920. S2CID 212639677.
  7. ^ "Coronavirus Q and A: We asked experts to answer some of your most pressing questions. Here's what they had to say". thestar.com. 2020-01-27. Retrieved 2020-04-06.
  8. ^ Chung, Hannah; Buchan, Sarah A; Campigotto, Aaron; Campitelli, Michael A; Crowcroft, Natasha S; Dubey, Vinita; Gubbay, Jonathan B; Karnauchow, Timothy; Katz, Kevin; McGeer, Allison J; McNally, J Dayre (2021-09-01). "Influenza Vaccine Effectiveness Against All-Cause Mortality Following Laboratory-Confirmed Influenza in Older Adults, 2010–2011 to 2015–2016 Seasons in Ontario, Canada". Clinical Infectious Diseases. 73 (5): e1191–e1199. doi:10.1093/cid/ciaa1862. ISSN 1058-4838. PMC 8423473. PMID 33354709.
  9. ^ Abe, Kento T.; Hu, Queenie; Mozafarihashjin, Mohammad; Samson, Reuben; Manguiat, Kathy; Robinson, Alyssia; Rathod, Bhavisha; Hardy, W. Rod; Wang, Jenny H.; Iskilova, Mariam; Pasculescu, Adrian (2021-08-27). "Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers". medRxiv 10.1101/2021.08.06.21261721v2.
  10. ^ Yau, Kevin; Abe, Kento T.; Naimark, David; Oliver, Matthew J.; Perl, Jeffrey; Leis, Jerome A.; Bolotin, Shelly; Tran, Vanessa; Mullin, Sarah I.; Shadowitz, Ellen; Gonzalez, Anny (2021-09-02). "Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis". JAMA Network Open. 4 (9): e2123622. doi:10.1001/jamanetworkopen.2021.23622. ISSN 2574-3805. PMC 8414193. PMID 34473256.
  11. ^ "New Sars warning in Toronto". The Guardian. Reuters. 2003-05-27. ISSN 0261-3077. Retrieved 2020-04-06.
  12. ^ "Canadian scientist remains cautious of new coronavirus: 'It is very reminiscent of SARS'". ottawacitizen.com. Retrieved 2020-04-06.
  13. ^ Krauss, Clifford (2003-04-24). "The Sars Epidemic: The Overview; Travelers Urged to Avoid Toronto Because of Sars". The New York Times. ISSN 0362-4331. Retrieved 2020-04-06.
  14. ^ McGeer, Allison (2004-07-15). "Let Him Who Desires Peace Prepare for War: United States Hospitals and Severe Acute Respiratory Syndrome Preparedness". Clinical Infectious Diseases. 39 (2): 275–277. doi:10.1086/421784. ISSN 1058-4838. PMC 7107923. PMID 15307039.
  15. ^ Mackay, Brad (2003-05-13). "SARS: "a domino effect through entire system"". CMAJ. 168 (10): 1308–1308–a. ISSN 0820-3946. PMC 154202. PMID 12743085.
  16. ^ "A specialist on front line forced to fight her own battle against SARS". Retrieved 2020-04-06.
  17. ^ a b Poutanen, Susan M.; McGeer, Allison J. (2004). "Transmission and Control of SARS". Current Infectious Disease Reports. 6 (3): 220–227. doi:10.1007/s11908-004-0012-7. ISSN 1523-3847. PMC 7089465. PMID 15142486.
  18. ^ Raboud, Janet; Shigayeva, Altynay; McGeer, Allison; Bontovics, Erika; Chapman, Martin; Gravel, Denise; Henry, Bonnie; Lapinsky, Stephen; Loeb, Mark; McDonald, L. Clifford; Ofner, Marianna (2010-05-19). "Risk Factors for SARS Transmission from Patients Requiring Intubation: A Multicentre Investigation in Toronto, Canada". PLOS ONE. 5 (5): e10717. Bibcode:2010PLoSO...510717R. doi:10.1371/journal.pone.0010717. ISSN 1932-6203. PMC 2873403. PMID 20502660.
  19. ^ "WORLD: How doctors trace an outbreak". ThoroldNews.com. 12 February 2020. Retrieved 2020-04-06.
  20. ^ Loeb, Mark; McGeer, Allison; Henry, Bonnie; Ofner, Marianna; Rose, David; Hlywka, Tammy; Levie, Joanne; McQueen, Jane; Smith, Stephanie; Moss, Lorraine; Smith, Andrew (2004). "SARS among Critical Care Nurses, Toronto". Emerging Infectious Diseases. 10 (2): 251–255. doi:10.3201/eid1002.030838. ISSN 1080-6040. PMC 3322898. PMID 15030692.
  21. ^ a b . www.lmp.utoronto.ca. Archived from the original on 2020-04-06. Retrieved 2020-04-06.
  22. ^ Branswell, Helen (2013-06-04). "WHO expert team, including Canadian, in Saudi investigating MERS outbreak". CTVNews. Retrieved 2020-04-06.
  23. ^ "Middle East Respiratory Syndrome (MERS) virus investigation". ScienceDaily. Retrieved 2020-04-06.
  24. ^ "Can you have coronavirus and not feel sick? A doctor answers your COVID-19 questions". CBC. 2020-03-18. Retrieved 2020-04-06.
  25. ^ a b Nanowski, Natalie (2020-03-12). "The COVID-19 pandemic: What it is, who's at risk, and how you can protect yourself". Retrieved 2020-04-06.
  26. ^ . Mayjorad Pharmacies. Archived from the original on 2020-04-06. Retrieved 2020-04-06.
  27. ^ a b "About Us". Ontario COVID-19 Science Advisory Table. Retrieved 2022-03-17.
  28. ^ a b "COVID-19 Expert Panel". Government of Canada. 2021-01-14. Archived from the original on 2021-11-29. Retrieved 2022-03-17.
  29. ^ "U of T infectious disease expert Allison McGeer on coronavirus risks – and uncertainties". University of Toronto News. Retrieved 2020-04-06.
  30. ^ Branswell,STAT, Helen. "Experts Warn of Possible Sustained Global Spread of New Coronavirus". Scientific American. Retrieved 2020-04-06.
  31. ^ "Containing new coronavirus may not be feasible, experts say". STAT. 2020-01-26. Retrieved 2020-04-06.
  32. ^ a b Miller, Adam. "'The time is now to act': COVID-19 spreading in Canada with no known link to travel, previous cases". CBC News. Retrieved 2020-04-06.
  33. ^ Ireland, Nicole. "COVID-19: The latest guidance for Canadians on travel, quarantines and what to do if you have symptoms". 2020-03-12. Retrieved 2020-04-06.
  34. ^ a b c d e "Scientists look for signs of air transmission of COVID-19". The Globe and Mail Inc. 2 April 2020. Retrieved 2020-04-06.
  35. ^ "The coronavirus question: To mask or not to mask". Macleans. Retrieved 2020-04-06.
  36. ^ Bégin, Philippe; Callum, Jeannie; Jamula, Erin; Cook, Richard; Heddle, Nancy M.; Tinmouth, Alan; Zeller, Michelle P.; Beaudoin-Bussières, Guillaume; Amorim, Luiz; Bazin, Renée; Loftsgard, Kent Cadogan (2021). "Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial". Nature Medicine. 27 (11): 2012–2024. doi:10.1038/s41591-021-01488-2. ISSN 1078-8956. PMC 8604729. PMID 34504336.
  37. ^ Canadian Institutes of Health Research (9 September 2010). "Assessing the Association Between Frailty and Outcome of COVID-19 Infection". Canadian Research Information System. Archived from the original on 2022-03-26. Retrieved 2022-03-26.
  38. ^ Semeniuk, Ivan (2021-05-08). "Once a little-known health body, NACI finds itself in the pandemic spotlight over COVID-19 vaccine debate". The Globe and Mail. Retrieved 2022-03-17.
  39. ^ Ireland, Nicole (2021-09-29). "COVID-19 vaccine boosters recommended for long-term care residents, national advisory committee says". CBC News. Retrieved 2022-03-17.
  40. ^ a b c "Ontario Immunization Advisory Committee (OIAC)". Public Health Ontario. Archived from the original on 2021-11-10. Retrieved 2022-03-17.
  41. ^ "Expert Advisory Group on Antimicrobial Resistance (EAGAR) - Membership". Public Health Agency of Canada. 2021-06-11. Archived from the original on 2022-01-27. Retrieved 2022-03-17.
  42. ^ "Partners – Page 11". National Collaborating Centre for Infectious Diseases. Archived from the original on 2022-01-16. Retrieved 2022-03-17.
  43. ^ "Toronto's 30 Best Doctors". Toronto Life. 2014-03-05. Retrieved 2020-04-06.
  44. ^ "May Cohen Award for Women Mentors". Canadian Medical Association. 2015.
  45. ^ "AMMI Canada Lifetime Achievement Award". Association of Medical Microbiology and Infectious Disease Canada. 2016.
  46. ^ "Norman Rosenblum Award for Excellence in Mentorship in the MD/PhD Program". University of Toronto MD Program. 2021.
  47. ^ "2021 Annual Conference Final Program" (PDF). AMMI Canada - CACMID. 2021-04-25. Retrieved 2022-03-17.

External links edit

December 15, 2023
allison, mcgeer, allison, joan, mcgeer, frcpc, born, 1953, canadian, infectious, disease, specialist, sinai, health, system, professor, department, laboratory, medicine, pathobiology, university, toronto, also, appointed, dalla, lana, school, public, health, s. Allison Joan McGeer FRCPC born 1953 is a Canadian infectious disease specialist in the Sinai Health System and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld Tanenbaum Research Institute and is a partner of the National Collaborating Centre for Infectious Diseases McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low During the COVID 19 pandemic McGeer has studied how SARS CoV 2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario s pandemic response Allison McGeerBorn1953 age 69 70 Alma materUniversity of Toronto BS MSc MD Known forPandemic response SARS coronavirus research vaccine approval public health guidanceScientific careerInstitutionsSinai Health SystemDalla Lana School of Public HealthLunenfeld Tanenbaum Research InstituteDepartment of Laboratory Medicine amp Pathobiology at the University of Toronto Contents 1 Early life and education 2 Career 2 1 SARS and MERS 2 2 COVID 19 pandemic 3 Membership 4 Awards 5 Selected works and publications 6 See also 7 References 8 External linksEarly life and education editIn 1974 McGeer earned a B Sc in biochemistry from the University of Toronto 1 She earned a master s degree and then an M D in 1982 1 2 She trained in internal medicine and infectious diseases at the University of Toronto From 1989 to 1990 McGeer was a clinical fellow in hospital epidemiology at Yale New Haven Hospital 2 Career editIn 1989 McGeer joined the Sinai Health System where she specialised in microbiology 2 She holds a joint position as Professor in the Department of Laboratory Medicine and Pathobiology and of Infectious Diseases at the Dalla Lana School of Public Health 3 At the University of Toronto she has focussed on developing mechanisms to stop the spread of infectious diseases in hospitals and care homes 2 4 McGeer has studied the impact of influenza on hospital staff She encouraged people of all ages to receive the universal flu vaccine and supported hospitals in improving their influenza testing 5 She also contributed to a review of influenza diagnosis among older hospitalized patients on behalf of the Canadian Immunization Research Network CIRN Serious Outcomes Surveillance SOS Network 6 She is the director of infection control and works as a microbiologist and infectious disease consultant at the Mount Sinai Hospital Her staff directory page acknowledges funding through an unrestricted educational grant from Pfizer Canada 2 McGeer studies the prevention and management of bacterial and viral infections 7 Her primary areas of research interest are the prevention of healthcare associated infection the epidemiology of influenza and adult immunization She has received research grants from Pfizer and Seqirus as well as personal and consulting fees from AstraZeneca GlaxoSmithKline Janssen Medicago Merck Moderna and Sanofi Pasteur 8 9 10 SARS and MERS edit McGeer led the investigations into Severe Acute Respiratory Syndrome SARS in Toronto 11 12 13 14 She was based at the Ontario SARS emergency operation centre At the time she contracted the disease 15 and accidentally exposed several other health officials to the disease 16 The health officials were quarantined and did not develop the disease The basic reproduction number of severe acute respiratory syndrome related coronavirus SARS CoV was between 2 2 and 3 7 but super spreading events highly efficient transmission of the virus occurred in some hospital settings 17 18 McGeer believes that Toronto eliminated SARS by isolating people who were infected or at risk from the virus preventing its spread 19 A study the critical care units of Toronto s hospitals found that the consistent use of N95 masks was an effective way to protect nurses 17 20 During the 2013 MERS outbreak McGeer visited Saudi Arabia with the World Health Organization to help to track the spread of the virus 21 22 23 Through careful monitoring of the air food and water supply McGeer helped to control the spread of the virus 21 COVID 19 pandemic edit Throughout the COVID 19 pandemic McGeer provided health advice to the Canadian public 24 25 26 including as a member of the Ontario COVID 19 Science Advisory Table 27 She also serves on Canada s COVID 19 Expert Panel assembled by Chief Science Advisor of Canada Dr Mona Nemer to assist in providing advice and guidance to Prime Minister Justin Trudeau and the federal government 28 In late January 2020 McGeer expressed concerns over the ability to contain SARS CoV 2 29 30 particularly the unknown incubation period which makes it difficult to track and quarantine people who have been exposed 31 In early March she emphasized the need for Canadians to follow public health advice to prevent the widespread transmission of SARS CoV 2 32 According to McGeer the most important guidance was to limit social contact and stay at home when feeling unwell 25 32 33 McGeer started to investigate how long SARS CoV 2 can survive in air in March 2020 34 She was interested in how exhaled droplets which contain both water and the virus may become an infective aerosol that is light enough to be transported by air currents 34 Caroline Duchaine an aerosol specialist at the Universite Laval thinks that the virus may not be as potent in aerosol form losing parts of its spiky protein shell as it dries out in the air 34 McGeer and Duchaine are interested in how the virus survives in air in a hospital setting particularly around patients who are being intubated 34 She hopes her research will provide insight as to whether face masks should be worn to reduce the transmission of the virus 34 At the time the Centers for Disease Control and Prevention were considering whether to advise members of the public to wear masks when they left the house and they had been made mandatory in the Czech Republic 35 In her role at Mount Sinai Hospital McGeer acted as a local principal investigator for the CONvalescent Plasma for Hospitalized Adults With COVID 19 Respiratory Illness CONCOR 1 study 36 She also served as a principal investigator on a study examining the association between frailty and outcomes of COVID 19 infection 37 In May 2021 McGeer explained that National Advisory Committee on Immunization NACI deliberations to approve COVID 19 vaccines couldn t be made available to the public because the agency has nothing like the budget or staff that would be needed to do so While NACI is mandated to gather and evaluate the available data relevant to vaccines McGeer also noted they are not adequately resourced for rapid and comprehensive scientific assessment 38 She welcomed NACI s September 2021 recommendation of a COVID 19 vaccine booster shot for residents of long term and congregate care facilities citing evidence of waning immunity among this population 39 McGeer was recruited as a member of the newly formed Ontario Immunization Advisory Committee OIAC created by Chief Medical Officer of Health Kieran Moore in August 2021 to work on provincial vaccine programs including for COVID 19 40 Membership editCanada s COVID 19 Expert Panel 28 Canada s Expert Advisory Group on Antimicrobial Resistance EAGAR 41 Canada s National Advisory Committee on Immunization 2 40 National Collaborating Centre for Infectious Diseases partner 42 Ontario COVID 19 Science Advisory Table 27 Ontario Immunization Advisory Committee 40 Ontario Provincial Infectious Diseases Advisory Committee infection control subcommittee member 2 Awards edit2014 Toronto Life Toronto s 30 Best Doctors 43 2015 Canadian Medical Association May Cohen Award for Women Mentors 44 2016 Association of Medical Microbiology and Infectious Disease Canada Lifetime Achievement Award 45 2021 University of Toronto Faculty of Medicine Norman Rosenblum Award for Excellence in Mentorship in the MD PhD Program 46 2021 Canadian Association for Clinical Microbiology and Infectious Diseases John G FitzGerald CACMID Outstanding Microbiologist Award 47 Selected works and publications edit nbsp Scholia has an author profile for Allison McGeer Chen Danny K McGeer Allison de Azavedo Joyce C Low Donald E 1999 07 22 Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada New England Journal of Medicine 341 4 233 239 doi 10 1056 NEJM199907223410403 ISSN 0028 4793 PMID 10413735 nbsp Wikidata Nuorti J Pekka Butler Jay C Farley Monica M Harrison Lee H McGeer Allison Kolczak Margarette S Breiman Robert F 2000 03 09 Cigarette Smoking and Invasive Pneumococcal Disease New England Journal of Medicine 342 10 681 689 doi 10 1056 NEJM200003093421002 ISSN 0028 4793 PMID 10706897 nbsp Wikidata Poutanen Susan M Low Donald E Henry Bonnie Finkelstein Sandy Rose David Green Karen Tellier Raymond Draker Ryan Adachi Dena Ayers Melissa Chan Adrienne K 2003 05 15 Identification of Severe Acute Respiratory Syndrome in Canada New England Journal of Medicine 348 20 1995 2005 doi 10 1056 NEJMoa030634 ISSN 0028 4793 PMID 12671061 nbsp Wikidata Assiri Abdullah McGeer Allison Perl Trish M Price Connie S Al Rabeeah Abdullah A Cummings Derek A T Alabdullatif Zaki N Assad Maher Almulhim Abdulmohsen Makhdoom Hatem Madani Hossam Alhakeem Rafat Al Tawfiq Jaffar A Cotten Matthew Watson Simon J Kellam Paul Zumla Alimuddin I Memish Ziad A August 2013 Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus New England Journal of Medicine 369 5 407 416 doi 10 1056 NEJMOA1306742 PMC 4029105 PMID 23782161 nbsp Wikidata Alhazzani Waleed Moller Morten Hylander Arabi Yaseen M Loeb Mark Gong Michelle Ng Fan Eddy Oczkowski Simon Levy Mitchell M Derde Lennie Dzierba Amy Du Bin Aboodi Michael Wunsch Hannah Cecconi Maurizio Koh Younsuck Chertow Daniel S Maitland Kathryn Alshamsi Fayez Belley Cote Emilie Greco Massimiliano Laundy Matthew Morgan Jill S Kesecioglu Jozef McGeer Allison Mermel Leonard Mammen Manoj J Alexander Paul E Arrington Amy Centofanti John E et al 2020 Surviving Sepsis Campaign Guidelines on the management of critically ill adults with Coronavirus Disease 2019 COVID 19 Intensive Care Medicine 46 5 854 887 doi 10 1007 s00134 020 06022 5 PMC 7101866 PMID 32222812 See also editCOVID 19 pandemic in Canada Maurizio CecconiReferences edit a b Pandemic 3 0 University of Toronto Medicine Magazine Faculty of Medicine 26 March 2014 Archived from the original on 28 June 2014 Retrieved 8 April 2020 a b c d e f g Staff Directory Allison McGeer eportal mountsinai ca Retrieved 2020 04 06 Allison Mcgeer Institute of Health Policy Management and Evaluation ihpme utoronto ca Archived from the original on 2016 08 21 Retrieved 2020 04 06 Laboratory Medicine and Pathobiology University of Toronto www lmp utoronto ca Archived from the original on 2020 04 06 Retrieved 2020 04 06 Dr Allison McGeer answers common questions about the flu and the flu shot Sinai Health 2018 10 17 Retrieved 2020 04 06 Andrew Melissa K McElhaney Janet E McGeer Allison A Hatchette Todd F Leblanc Jason Webster Duncan Bowie William Poirier Andre Nichols Michaela K McNeil Shelly A Investigators on behalf of the Canadian Immunization Research Network CIRN Serious Outcomes Surveillance Network 2020 03 09 Influenza surveillance case definitions miss a substantial proportion of older adults hospitalized with laboratory confirmed influenza A report from the Canadian Immunization Research Network CIRN Serious Outcomes Surveillance SOS Network Infection Control amp Hospital Epidemiology 41 5 499 504 doi 10 1017 ice 2020 22 ISSN 0899 823X PMID 32146920 S2CID 212639677 Coronavirus Q and A We asked experts to answer some of your most pressing questions Here s what they had to say thestar com 2020 01 27 Retrieved 2020 04 06 Chung Hannah Buchan Sarah A Campigotto Aaron Campitelli Michael A Crowcroft Natasha S Dubey Vinita Gubbay Jonathan B Karnauchow Timothy Katz Kevin McGeer Allison J McNally J Dayre 2021 09 01 Influenza Vaccine Effectiveness Against All Cause Mortality Following Laboratory Confirmed Influenza in Older Adults 2010 2011 to 2015 2016 Seasons in Ontario Canada Clinical Infectious Diseases 73 5 e1191 e1199 doi 10 1093 cid ciaa1862 ISSN 1058 4838 PMC 8423473 PMID 33354709 Abe Kento T Hu Queenie Mozafarihashjin Mohammad Samson Reuben Manguiat Kathy Robinson Alyssia Rathod Bhavisha Hardy W Rod Wang Jenny H Iskilova Mariam Pasculescu Adrian 2021 08 27 Neutralizing antibody responses to SARS CoV 2 variants in vaccinated Ontario long term care home residents and workers medRxiv 10 1101 2021 08 06 21261721v2 Yau Kevin Abe Kento T Naimark David Oliver Matthew J Perl Jeffrey Leis Jerome A Bolotin Shelly Tran Vanessa Mullin Sarah I Shadowitz Ellen Gonzalez Anny 2021 09 02 Evaluation of the SARS CoV 2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis JAMA Network Open 4 9 e2123622 doi 10 1001 jamanetworkopen 2021 23622 ISSN 2574 3805 PMC 8414193 PMID 34473256 New Sars warning in Toronto The Guardian Reuters 2003 05 27 ISSN 0261 3077 Retrieved 2020 04 06 Canadian scientist remains cautious of new coronavirus It is very reminiscent of SARS ottawacitizen com Retrieved 2020 04 06 Krauss Clifford 2003 04 24 The Sars Epidemic The Overview Travelers Urged to Avoid Toronto Because of Sars The New York Times ISSN 0362 4331 Retrieved 2020 04 06 McGeer Allison 2004 07 15 Let Him Who Desires Peace Prepare for War United States Hospitals and Severe Acute Respiratory Syndrome Preparedness Clinical Infectious Diseases 39 2 275 277 doi 10 1086 421784 ISSN 1058 4838 PMC 7107923 PMID 15307039 Mackay Brad 2003 05 13 SARS a domino effect through entire system CMAJ 168 10 1308 1308 a ISSN 0820 3946 PMC 154202 PMID 12743085 A specialist on front line forced to fight her own battle against SARS Retrieved 2020 04 06 a b Poutanen Susan M McGeer Allison J 2004 Transmission and Control of SARS Current Infectious Disease Reports 6 3 220 227 doi 10 1007 s11908 004 0012 7 ISSN 1523 3847 PMC 7089465 PMID 15142486 Raboud Janet Shigayeva Altynay McGeer Allison Bontovics Erika Chapman Martin Gravel Denise Henry Bonnie Lapinsky Stephen Loeb Mark McDonald L Clifford Ofner Marianna 2010 05 19 Risk Factors for SARS Transmission from Patients Requiring Intubation A Multicentre Investigation in Toronto Canada PLOS ONE 5 5 e10717 Bibcode 2010PLoSO 510717R doi 10 1371 journal pone 0010717 ISSN 1932 6203 PMC 2873403 PMID 20502660 WORLD How doctors trace an outbreak ThoroldNews com 12 February 2020 Retrieved 2020 04 06 Loeb Mark McGeer Allison Henry Bonnie Ofner Marianna Rose David Hlywka Tammy Levie Joanne McQueen Jane Smith Stephanie Moss Lorraine Smith Andrew 2004 SARS among Critical Care Nurses Toronto Emerging Infectious Diseases 10 2 251 255 doi 10 3201 eid1002 030838 ISSN 1080 6040 PMC 3322898 PMID 15030692 a b The mysteries of microbiology Q amp A with Professor Allison McGeer Laboratory Medicine and Pathobiology University of Toronto www lmp utoronto ca Archived from the original on 2020 04 06 Retrieved 2020 04 06 Branswell Helen 2013 06 04 WHO expert team including Canadian in Saudi investigating MERS outbreak CTVNews Retrieved 2020 04 06 Middle East Respiratory Syndrome MERS virus investigation ScienceDaily Retrieved 2020 04 06 Can you have coronavirus and not feel sick A doctor answers your COVID 19 questions CBC 2020 03 18 Retrieved 2020 04 06 a b Nanowski Natalie 2020 03 12 The COVID 19 pandemic What it is who s at risk and how you can protect yourself Retrieved 2020 04 06 The 2019 coronavirus is not like SARS Dr Allison McGeer Mayjorad Pharmacies Archived from the original on 2020 04 06 Retrieved 2020 04 06 a b About Us Ontario COVID 19 Science Advisory Table Retrieved 2022 03 17 a b COVID 19 Expert Panel Government of Canada 2021 01 14 Archived from the original on 2021 11 29 Retrieved 2022 03 17 U of T infectious disease expert Allison McGeer on coronavirus risks and uncertainties University of Toronto News Retrieved 2020 04 06 Branswell STAT Helen Experts Warn of Possible Sustained Global Spread of New Coronavirus Scientific American Retrieved 2020 04 06 Containing new coronavirus may not be feasible experts say STAT 2020 01 26 Retrieved 2020 04 06 a b Miller Adam The time is now to act COVID 19 spreading in Canada with no known link to travel previous cases CBC News Retrieved 2020 04 06 Ireland Nicole COVID 19 The latest guidance for Canadians on travel quarantines and what to do if you have symptoms 2020 03 12 Retrieved 2020 04 06 a b c d e Scientists look for signs of air transmission of COVID 19 The Globe and Mail Inc 2 April 2020 Retrieved 2020 04 06 The coronavirus question To mask or not to mask Macleans Retrieved 2020 04 06 Begin Philippe Callum Jeannie Jamula Erin Cook Richard Heddle Nancy M Tinmouth Alan Zeller Michelle P Beaudoin Bussieres Guillaume Amorim Luiz Bazin Renee Loftsgard Kent Cadogan 2021 Convalescent plasma for hospitalized patients with COVID 19 an open label randomized controlled trial Nature Medicine 27 11 2012 2024 doi 10 1038 s41591 021 01488 2 ISSN 1078 8956 PMC 8604729 PMID 34504336 Canadian Institutes of Health Research 9 September 2010 Assessing the Association Between Frailty and Outcome of COVID 19 Infection Canadian Research Information System Archived from the original on 2022 03 26 Retrieved 2022 03 26 Semeniuk Ivan 2021 05 08 Once a little known health body NACI finds itself in the pandemic spotlight over COVID 19 vaccine debate The Globe and Mail Retrieved 2022 03 17 Ireland Nicole 2021 09 29 COVID 19 vaccine boosters recommended for long term care residents national advisory committee says CBC News Retrieved 2022 03 17 a b c Ontario Immunization Advisory Committee OIAC Public Health Ontario Archived from the original on 2021 11 10 Retrieved 2022 03 17 Expert Advisory Group on Antimicrobial Resistance EAGAR Membership Public Health Agency of Canada 2021 06 11 Archived from the original on 2022 01 27 Retrieved 2022 03 17 Partners Page 11 National Collaborating Centre for Infectious Diseases Archived from the original on 2022 01 16 Retrieved 2022 03 17 Toronto s 30 Best Doctors Toronto Life 2014 03 05 Retrieved 2020 04 06 May Cohen Award for Women Mentors Canadian Medical Association 2015 AMMI Canada Lifetime Achievement Award Association of Medical Microbiology and Infectious Disease Canada 2016 Norman Rosenblum Award for Excellence in Mentorship in the MD PhD Program University of Toronto MD Program 2021 2021 Annual Conference Final Program PDF AMMI Canada CACMID 2021 04 25 Retrieved 2022 03 17 External links editAllison McGeer M D FRCPC at Mount Sinai Hospital Allison McGeer at the Department of Laboratory Medicine and Pathobiology Allison McGeer Archived 2016 08 21 at the Wayback Machine at Dalla Lana School of Public Health Dr Allison McGeer at Lunenfeld Tanenbaum Research Institute Retrieved from https en wikipedia org w index php title Allison McGeer amp oldid 1188274279, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.